JohnSampsonMDPhD, MBA

PubMed

• Utility of Routine Preoperative Urinalysis in the Prevention of Surgical Site Infections.
  Aden P Haskell-Mendoza, Senthil Radhakrishnan, Ana Lisa Nardin, Kristina Eilbacher, Lexie Zidanyue Yang, Joshua D Jackson, Hui-Jie Lee, John H Sampson, Peter E Fecci> ;World Neurosurgery. 2023 Dec 1
• 10 citations
  Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial.
  John H Sampson, Achal Singh Achrol, Manish K Aghi, Krystof Bankiewicz, Martin Bexon, Steven Brem, Andrew Brenner, Chandtip Chandhasin, Sajeel Chowdhary, Melissa Coello...> ;Neuro-Oncology. 2023 Jun 2
• 1 citations
  Novel Immunotherapeutic Approaches for the Treatment of Glioblastoma.
  Saïf Eddine Zaidi, Eliese Moelker, Kirit Singh, Aditya Mohan, Miguel A Salgado, Muhammed Amir Essibayi, Kelly Hotchkiss, Steven Shen, William Lee, John Sampson, Mustaf...> ;Biodrugs. 2023 Jul 1
• 10 citations
  IL7 and IL7 Flt3L co-expressing CAR T cells improve therapeutic efficacy in mouse EGFRvIII heterogeneous glioblastoma.
  Sheridan L Swan, Nalini Mehta, Ekaterina Ilich, Steven H Shen, Daniel S Wilkinson, Alexa R Anderson, Tatiana Segura, Luis Sanchez-Perez, John H Sampson, Ravi V Bellamk...> ;Frontiers in Immunology. 2023 Jan 1
• 2 citations
  Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic Radiosurgery.
  David J Carpenter, Andrew T Fairchild, Justus D Adamson, Peter E Fecci, John H Sampson, James E Herndon, Jordan A Torok, Trey C Mullikin, Grace J Kim, Zachary J Reitma...> ;Advances in Radiation Oncology. 2022 Dec 29
• 6 citations
  Multiepitope supramolecular peptide nanofibers eliciting coordinated humoral and cellular antitumor immune responses.
  Yaoying Wu, Hanning Wen, Zachary J Bernstein, Kelly M Hainline, Tykia S Blakney, Kendra L Congdon, David J Snyder, John H Sampson, Luis Sanchez-Perez, Joel H Collier> ;Science Advances. 2022 Jul 22
• 3 citations
  Risk Factors and Neurological Outcomes Associated With Circulatory Shock After Moderate-Severe Traumatic Brain Injury: A TRACK-TBI Study.
  Camilo Toro, Jordan Hatfield, Nancy Temkin, Jason Barber, Geoffrey Manley, Tetsu Ohnuma, Jordan Komisarow, Brandon Foreman, Frederick K Korley, Monica S Vavilala, Dani...> ;Neurosurgery. 2022 Sep 1
• 23 citations
  Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143.
  Antonio Omuro, David A Reardon, John H Sampson, Joachim Baehring, Solmaz Sahebjam, Timothy F Cloughesy, Alexandros-Georgios Chalamandaris, Von Potter, Nicholas Butowsk...> ;Neuro-Oncology Advances. 2022 Feb 26
• 3 citations
  Early Vasopressor Utilization Strategies and Outcomes in Critically Ill Patients With Severe Traumatic Brain Injury.
  Camilo Toro, Tetsu Ohnuma, Jordan Komisarow, Monica S Vavilala, Daniel T Laskowitz, Michael L James, Joseph P Mathew, Adrian F Hernandez, Ben A Goldstein, John H Samps...> ;Anesthesia and Analgesia. 2022 Dec 1
• 1 citations
  Generation of Tumor Targeted Dendritic Cell Vaccines with Improved Immunogenic and Migratory Phenotype.
  Adam M Swartz, Kelly M Hotchkiss, Smita K Nair, John H Sampson, Kristen A Batich> ;Methods in Molecular Biology. 2022 Jan 1
• 8 citations
  Utilization of Brain Tissue Oxygenation Monitoring and Association with Mortality Following Severe Traumatic Brain Injury
  Jordan M. Komisarow, Camilo Toro, Jonathan Curley, Brianna Mills, Christopher Cho, Georges Motchoffo Simo, Monica S. Vavilala, Daniel T. Laskowitz, Michael L. James, J...> ;Neurocritical Care. 2021 Nov 29
• 11 citations
  For whom the T cells troll? Bispecific T-cell engagers in glioblastoma
  Kirit Singh, Kelly Hotchkiss, Aditya Mohan, Jessica L. Reedy, John Sampson, Mustafa Khasraw> ;Journal for Immunotherapy of Cancer. 2021 Nov 1
• 8 citations
  Outcomes in Patients With 4 to 10 Brain Metastases Treated With Dose-Adapted Single-Isocenter Multitarget Stereotactic Radiosurgery: A Prospective Study
  Grace Kim, Evan Buckley, James E. Herndon, Karen Allen, Tyketra S. Dale, Justus Adamson, Lam Lay, William Giles, A Rodrigues, Zhiheng Wang, Chris R. Kelsey, Jordan A. ...> ;Advances in Radiation Oncology. 2021 Nov 1
• 9 citations
  Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma.
  Kirit Singh, Kelly Hotchkiss, Kisha K. Patel, Daniel Wilkinson, Aditya Mohan, Sarah L Cook, John Sampson> ;Cancers. 2021 Oct 26
• 3 citations
  Broad immunophenotyping of the murine brain tumor microenvironment.
  William H. Tomaszewski, Jessica Waibl-Polania, A.M. Miggelbrink, M.A. Chakraborty, Peter E. Fecci, John Sampson, Michael D. Gunn> ;Journal of Immunological Methods. 2021 Sep 28
• 14 citations
  Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma.
  Kirit Singh, Kristen A. Batich, Patrick Y. Wen, Aaron Tan, Stephen J Bagley, Michael Lim, Michael Platten, Howard Colman, David M. Ashley, Susan M. Chang, Rifaquat Rah...> ;Clinical Cancer Research. 2021 Sep 24
• 46 citations
  Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement.
  Stephen J Bagley, Shawn Kothari, Rifaquat Rahman, Eudocia Q. Lee, Gavin P. Dunn, Evanthia Galanis, Susan M. Chang, Louis B. Nabors, Manmeet S Ahluwalia, Roger Stupp, M...> ;Clinical Cancer Research. 2021 Sep 24
• 3 citations
  Association of Vasopressor Choice with Clinical and Functional Outcomes Following Moderate to Severe Traumatic Brain Injury: A TRACK-TBI Study
  Camilo Toro, Nancy R. Temkin, Jason Barber, Geoffrey T. Manley, Sonia Jain, Tetsu Ohnuma, Jordan M. Komisarow, Brandon Foreman, Frederick K. Korley, Monica S. Vavilala...> ;Neurocritical Care. 2021 Aug 2
• 17 citations
  Targeting Immunometabolism in Glioblastoma
  Aditya Mohan, William H. Tomaszewski, Aden P. Haskell-Mendoza, Kelly Hotchkiss, Kirit Singh, Jessica L. Reedy, Peter E. Fecci, John H. Sampson, Mustafa Khasraw> ;Frontiers in Oncology. 2021 Jun 16
• 15 citations
  Association of Early Multiple Organ Dysfunction With Clinical and Functional Outcomes Over the Year Following Traumatic Brain Injury: A Transforming Research and Clini...
  Vijay Krishnamoorthy, Nancy R. Temkin, Jason Barber, Brandon Foreman, Jordan M. Komisarow, Frederick K. Korley, Daniel T. Laskowitz, Joseph P. Mathew, Adrian F. Hernan...> ;Critical Care Medicine. 2021 May 3
• 17 citations
  Modified RANO, Immunotherapy RANO, and Standard RANO Response to Convection-Enhanced Delivery of IL4R-Targeted Immunotoxin MDNA55 in Recurrent Glioblastoma.
  Benjamin M. Ellingson, John H. Sampson, Achal S. Achrol, Manish K. Aghi, Krystof Krystof Bankiewicz, Chencai Wang, Martin Bexon, Steven Brem, Andrew Brenner, Sajeel Ch...> ;Clinical Cancer Research. 2021 Apr 16
• 9 citations
  A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope
  Adam M. Swartz, Kendra L. Congdon, Smita K. Nair, Qi-Jing Li, James E. Herndon, Carter M. Suryadevara, Katherine A. Riccione, Gary E. Archer, Pamela Norberg, Luis Sanc...> ;NPJ Vaccines. 2021 Jan 18
• 9 citations
  Association of Severe Acute Kidney Injury with Mortality and Healthcare Utilization Following Isolated Traumatic Brain Injury
  David Luu, Jordan M. Komisarow, Brianna Mills, Monica S. Vavilala, Daniel T. Laskowitz, Joseph P. Mathew, Michael L. James, Adrian F. Hernandez, John Sampson, Matt Ful...> ;Neurocritical Care. 2021 Jan 13
• 71 citations
  Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy.
  Matthias Gromeier, Michael C. Brown, Gao Zhang, Xiang Lin, Yeqing Chen, Zhi Wei, Nike Beaubier, Hai Yan, Yiping He, Annick Desjardins, James E. Herndon, Frederick S. V...> ;Nature Communications. 2021 Jan 13
• 36 citations
  Temozolomide treatment outcomes and immunotherapy efficacy in brain tumor
  Kelly Hotchkiss, John H. Sampson> ;Journal of Neuro-Oncology. 2021 Jan 1
• Join now to see all

Journal Articles

• Sequestration of T Cells in Bone Marrow in the Setting of Glioblastoma and Other Intracranial Tumors  
  Peter E Fecci, Cosette A Dechant, Robert L Martuza, Karolina Woroniecka, Brian V Nahed, James E Herndon, William T Curry, Aladine A Elsamadicy, John H Sampson, Michael..., Nature
• Complete response to steroids in dural inflammatory pseudotumor associated with Still's disease  
  Batich, K.B., St. Clair, E.W., McLendon, R.E., Sampson, J.H., J Clin Neurosci, 10/1/2013
• Isocitrate dehydrogenase 1 (IDH1): What it means to the neurosurgeon  
  Hodges, T.R., Choi, B.D., Bigner, D.D., Yan, H., Sampson, J.H., J Neurosurg, 6/1/2013
• Clinicopathological Characteristics and Treatment of Rhabdoid Glioblastoma  
  Babu, R., Hatef, J., McLendon, R., Cummings, T., Sampson, J.H., Friedman, A.H., Adamson, C., J Neurosurg, 5/3/2013
• A novel bispecific antibody recruits T cells to eradicate tumors in the "immunologically privileged" central nervous system  
  Choi, B.D., Pastan, I., Bigner, D.D., Sampson, J.H., Oncoimmunology, 4/1/2013
• Contemporary surgical management of vestibular schwannomas: analysis of complications and lessons learned over the past decade  
  Nonaka, Y., Fukushima, T., Watanabe, K., Friedman, A.H., Sampson, J.H., McElveen, J.T. Jr., Cunningham, C.D. 3rd, Zomorodi, A.R., Neurosurgery, 1/1/2013
• Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma  
  Choi, B.D., Kuan, C.T., Cai, M., Archer, G.E., Mitchell, D.A., Gedeon, P.C., Sanchez-Perez, L, Pastan, I., Bigner, D.D., Sampson, J.H., Proc. Natl. Acad. Sci. U.S.A., 1/1/2013
• Therapeutic approaches for HER2-positive brain metastases: circumventing the blood-brain barrier  
  Mehta, A.I, Brufsky, A.M., Sampson, J.H., Cancer Treat Rev, 1/1/2013
• Thickness of subcutaneous fat as a risk factor for infection in cervical spine fusion surgery  
  Mehta, A.I., Babu, R., Sharma, R., Karikari, I.O., Grunch, B.H., Owens, T.R., Agarwal, V.J., Sampson, J.H., Lad, S.P., Friedman, A.H., Kuchibhatla, M., Bagley, C.A., G..., J Bone Join Surg Am, 1/1/2013
• BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide  
  Sanchez-Perez, L., Choi, B., Reap, E., Sayour, E., Norberg, P., Schmittling, R., Archer, G., Herndon, II J., Mitchell, D.A., Heimberger, A., Bigner, D., Sampson, J.H., Canc Immunol Immunother, 1/1/2013
• Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trial  
  Cabrera, A.R., Cuneo, K.C., Desjardins, A., Sampson, J.H., McSherry, F., Herndon, JE., II, Peters, K.B., Allen, K.J., Hoang, J.K., Chang, Z., Craciunescu, O., Vredenbu..., Int J Radiat Oncol Biol Phys, 1/1/2013
• An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma  
  Reardon, D.A., Wucherpfennig, K.W., Freeman, G., Wu, C.J., Chiocca, E.A., Wen, P.Y., Curry, W.T., Jr., Mitchell, D.A., Fecci, P.E., Sampson, J.H., Dranoff, G., Expert Rev Vaccines, 1/1/2013
• Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis  
  Choi, B.D., Gedeon, P.C., Kuan, C.T., Bigner, D.D., Sampson, J.H., J Immunol Methods, 1/1/2013
• 107 Dose-finding and safety study of an oncolytic polio/rhinovirus recombinant against recurrent glioblastoma  
  Sampson, J.H., Desijardins, A., Peters, K.B., Ranjan, T., Vlahovic, G., Lally-Goss, D., Threatt, S., Herndon, J., Friedman, A.H., Friedman, H., Bigner, D., Gromeier, M, Neurosurgery, 1/1/2013
• Rindopepimut  
  Gedeon, P.C., Choi, B.D., Sampson, J.H., Bigner, D.D., Drugs Future, 1/1/2013
• Radiotherapy and radiosurgery for tumors of the central nervous system  
  Kirkpatrick, J.P., Yin, F.F., Sampson, J.H., Surg Oncol Clin N Am, 1/1/2013
• Melanoma immunotherapy using mature DCs expressing the constitutive proteasome  
  Dannull, J., Haley, N.R., Archer, G.E., Nair, S., Boczkowski, D., Harper, M., De Rosa, N., Pickett, N., Mosca, P.J., Burchette, J., Selim, M.A., Mitchell, D.A., Sampso..., J Clin Invest, 1/1/2013
• An EGFRvIII-targeted bispecific antibody overcomes limitations of the current standard of care for glioblastoma by inducing tumor cell specific cytotoxicity  
  Gedeon, P.C., Choi, B.D., Hodges, T.R., Mitchell, D.A., Bigner, D.D., Sampson, J.H., Expert Rev Clin Pharmacol, 1/1/2013
• A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model  
  Yang, S., Archer, G.E., Flores, C.E., Mitchell, D.A., Sampson, J.H., Cancer Immunol Immunother, 1/1/2013
• Immunotherapy with tumor vaccines for the treatment of malignant gliomas  
  Ajay, D., Sanchez-Perez, L, Choi, B.D., De Leon, G., Sampson, J.H., Curr Drug Discov Technol, 12/1/2012
• Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas  
  Cuneo, K.C., Vredenburgh, J.J., Sampson, J.H., Reardon, D.A., Desjardins, A., Peters, K.L., Willett, C.G., Kirkpatrick, J.P., Int. J. Radiat. Oncol. Biol. Phys., 4/1/2012
• Editorial: Disparities in Care  
  Sampson, J.H., Bagley, C.A., Carson, B.S., J Neurosurg, 2/1/2012
• Phase II study of carboplatin, irinotecan and bevacizumab for bevacizumab naïve, recurrent glioblastoma  
  Reardon, D.A., Desjardins, A., Peters, K.B., Gururangan, S., Sampson, J.H., McLendon, R.E., Herndon, J.E. II, Bulusu, A., Threatt, S., Friedman, A.H., Vredenburgh, J.J..., J Neurooncol, 1/1/2012
• Editorial: Avastin: More questions than answers  
  Desjardins, A., Sampson, J.H., J Neurosurg, 1/1/2012
• Editorial: Clinical data simplified  
  Sampson, J.H., Herndon, J.E., McLendon, R.E., Hasselblad, V., Asher, A.L., McGirt, M.J., Petereson, E.D., J Neurosurg, 1/1/2012
• Join now to see all

Books/Book Chapters

• Glioma: Symptoms, Diagnosis and Treatment Options. 
  Chapter: Current immunotherapeutic targets in gliomas. 
  Chandramohan, V., Mitchell, D.A., Gromeier, M., Sampson, J.H., and Bigner, D.D.Editors: Vrionis, F.D., Wiranowska, M.Nova Science Publishers, Inc.2013
• Drug Delivery to the Central Nervous System. 
  Chapter: Convection-enhanced drug delivery to the brain. 
  Page 893 - 2336Ding, D., Kanaly, C.W., Brady, M.L., Mittermeyer, S., Raghavan, R., Sampson, J.H.Editors: Jain K.Springer, New York, NY2010
• Neurosurgical Operative Atlas, Functional Neurosurgery. 
  Chapter: Microvascular decompression of the facial nerve for hemifacial spasm. 
  Sampson, J.H., Ellis, M.J., Grossi, P.M., Fukushima, T.Editors: Starr, P., Barbaro N., and Larson, L..Thieme, New York, NYEdition 2nd,2009
• Russell and Rubinstein's Pathology of Tumors of the Nervous System. 
  Chapter: Cellular and Humoral Immunity of Brain Tumors. 
  Page 167 - 230Bigner, D., Sampson J.H.Editors: Bigner, D.D., McLendon, R.E., and Bruner, J.M..Oxford University Press, New York, NYEdition 7th,2006
• The Textbook of Neuro-Oncology. 
  Chapter: Brain metastases for malignant melanoma. 
  Page 430 - 438Sampson, J.H., Shafman, T.D., Carter, Jr., J.H., Friedman, A.H., Seigler, H.F.Editors: Berger, M., and Black, P.M..Elsevier, Philadelphia, PA2005
• Brain Tumors. 
  Chapter: Immunotherapy of Central Nervous System Tumors. 
  Page 323 - 342Heimberger, A., Reardon, D., Bigner, D., Sampson, J.H.Editors: Ali-Osman, F..Humana Press, Totowa, NJ2004
• Glioblastoma Multiforme. 
  Chapter: Adoptive immunotherapy for malignant glioma. 
  Page 206 - 225Mitchell, D.A., Fecci, P.E., Sampson J.H.Editors: Markert, J., DeVita, V., Hellman, S., and Rosenberg, S..Jones and Bartlett Publishers, Sudbury, MA2004
• Modern Neurosurgery: Clinical Translation of Neuroscience Advances. 
  Chapter: Novel Therapeutic Approaches for High-Grade Gliomas. 
  Page 159 - 184New, K., Adamson, D., Selznick, L., and Sampson, J.H.Editors: Turner, D.A..CRC Press, New York, NY2004
• Cancer Handbook. 
  Chapter: Models for CNS malignancies. 
  Page 1123 - 1138Crotty, L.E., Sampson, J.H., Archer, G.E., and Bigner, D.D.Editors: Alison, M.R..Nature Publishing Group, London2002
• Neurosurgery. The Scientific Basis of Clinical Practice. 
  Chapter: The use of experimental models in neurooncological research. 
  Page 596 - 607Sampson, J.H., Archer, G.E., and Bigner, D.D.Editors: Crockard, A., Hayward, R., and Hoff, J..Blackwell Scientific Publications, Oxford, United Kingdom2001
• Brain Tumor Immunotherapy. 
  Chapter: Biological principles of brain tumor immunotherapy. 
  Page 101 - 130Heimberger, A.B., Bigner, D.D., and Sampson, J.H.Editors: Liau, L.M., Becker, D.P., Cloughesy, T.F., and Bigner, D.D..Humana Press, Totowa, NJ2001
• Operative Neurosurgery. 
  Chapter: Surgery for Idiopathic Vagoglossopharyngeal neuralgia. 
  Page 1635 - 1646Sampson, J.H. and Wilkins, R.H.Editors: Kaye, A.H., and Black, P.McL..Churchill Livingstone, London2000
• Gene Transfer and Therapy for Neurological Disease. 
  Chapter: Cytokine-based gene therapy for brain tumors. 
  Page 251 - 304Sampson, J.H., Bigner, D.D., and Dranoff, G.Editors: Chiocca, E.A., and Breakefield, X.O..Humana Press, Totowa, NJ1998
• Russell and Rubinstein's Pathology of Tumors of the Nervous System. 
  Chapter: Experimental tumors and the evaluation of neurocarcinogens. 
  Page 167 - 230Sampson, J.H., and Bigner, D.D.Editors: Bigner, D.D., McLendon, R.E., and Bruner, J.M..Arnold, LondonEdition 6th,1998
• Neurological Surgery: A Comprehensive Reference Guide to the Diagnosis and Management of Neurosurgical Problems. 
  Chapter: Dorsal root entry zone lesions for pain relief. 
  Page 3452 - 3462Nashold, B.S., Jr., Friedman, A.H., Sampson, J.H., Nashold, J.R.B., El-Naggar, A.O.Editors: Youmans, J.R..W.B. Saunders, Philadelphia, PA1996
• Neurosurgery. 
  Chapter: Genetic factors in brain tumors. 
  Page 665 - 671Sampson, J.H., and Martuza, R.L.Editors: Wilkins, R.H., and Rengachary, S.S..McGraw Hill, New York, NYEdition 2nd,1996
• Neurosurgery. 
  Chapter: Neurofibromatosis and other phakomatoses. 
  Page 673 - 685Sampson, J.H., and Martuza, R.L.Editors: Wilkins, R.H., and Rengachary, S.S..McGraw Hill, New York, NYEdition 2nd,1996
• Neurosurgery. 
  Chapter: Paragangliomas of the carotid and temporal bodies. 
  Page 1559 - 1571Sampson, J.H., and Wilkins, R.H.Editors: Wilkins, R.H., and Rengachary, S.S..McGraw Hill, New York, NYEdition 2nd,1996
• Neurosurgery. 
  Chapter: Lumbar spondylolisthesis. 
  Page 3851 - 3858Sampson, J.H., and Wilkins, R.H.Editors: Wilkins, R.H., and Rengachary, S.S..McGraw Hill, New York, NYEdition 2nd,1996
• Neurosurgery. 
  Chapter: Dorsal root entry zone lesions for pain relief. 
  Page 4035 - 4046Nashold, B.S., Jr., Sampson, J.H., Nashold, J.R.B., Higgins, A.C., and Blumenkopf, B.Editors: Wilkins, R.H., and Rengachary, S.S..McGraw Hill, New York, NYEdition 2nd,1996
• The DREZ Operation. 
  Chapter: DREZ lesions for intractable pain after trauma to the conus medullaris and cauda equina. 
  Page 147 - 158Sampson, J.H.Editors: Nashold, B.S., Jr., Pearlstein, R., Friedman, A.H., and Ovelmen Levitt, J..American Association of Neurological Surgeons, Park Ridge, IL1996
• Conn's Current Therapy. 
  Chapter: Acute head injuries in children. 
  Page 901 - 906Oakes, W.J., and Sampson, J.H.Editors: Rakel, R.E..W.B. Saunders, Philadelphia, PA1992
• Basic References in Neurosurgery. 
  Wilkins, R.H., and Sampson, J.H.American Association of Neurological Surgeons, Park Ridge, IL1992
• Basic References in Neurosurgery. 
  Wilkins, R.H., and Sampson, J.H.American Association of Neurological Surgeons, Park Ridge, IL1992
• Join now to see all

Abstracts/Posters

• Safety results from a prospective study of concurrent radiosurgery and bevacizumab for recurrent malignant glioma.
  Cuneo, K.C., Cabrera, A.R., Sampson, J.H., Allen, K.J., Vredenburgh, J.J., Peters, K., Chang, Z., Herndon, J.E., Desjardins, A., Reardon, D.A., Kirkpatrick, J., J Clin Oncol, 1/1/2011
• Concurrent Bevacizumab and Radiosurgery for Recurrent Malignant Glioma: Toxicity Results from a Prospective Pilot Study.
  Cuneo, K.C., Cabrera, A.R., Sampson, J.H., Allen, K., Duffy, E., Vredenburgh, J.J., Peters, K.B., Chang, Zheng, Desjardins, A., Kirkpatrick, J.P., ASTRO, Int J Radiat Oncol Biol Phys, 1/1/2011
• Dendritic cell vaccines targeting cytomegalovirus in glioblastoma.
  Mitchell, D.A., Archer, G.E., Friedman, H.S., Herndon, J.E., Bigner, D.D., Sampson, J.H., 16th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2011
• Cytomegalovirus-specific immune deficits in patients with GBM.
  Johnson, L.A., Archer, G.E., Nair, S.K., Schmittling, R., Reap, E., Sampson, J.H., Mitchell, D.A., 16th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2011
• Poor Coverage as a Possible Explanation for the Low Efficacy Results with CED: Simulation Analysis of Patients from the PRECISE Study.
  Sampson, J.H., Pedain, C., Wembacher-Schroder, Rodriguez-Ponce, I., Westphal, M., Kunwar, S., Vogelbaum, M.A., Raghavan, R., Brady, M., Friedman, A.H., Friedman, H.S.,..., J Neurosurg, 5/1/2009
• Interim data for ACT III - phase II trial of PF-04948568 (CDX-110) in combination with temozolomide (TMZ) in patients (pts) with glioblastoma (GBM).
  Lai, R., Recht, L.D., Reardon, D.A., Paleologos, N., Groves, M.D., Rosenfeld, M.R., Meech, S., Davis, T.A., Pavlov, D., Sampson, J.H., 46th Annual Meeting, American Society of Clinical Oncology, J Clin Oncol, 1/1/2009
• Humoral and cell-mediated immune responses to EGFRvIII-targeted vaccine (CDX-110) are enhanced with continuous temozolomide in patients with GBM.
  Archer, G.A., Heimberger, A., Pelloski, C., Hussain, S., Sun, W., Suki, D., Hess, K., Shi, W., Aldape, K., Gilbert, M., Sawaya, R., Schmittling, B., Archer, G., Herndo..., Proc Am Assoc Cancer Res, 4/1/2008
• Temozolomide enhances efficacy of EGFRvIII vaccine (CDX-110) in patients with newly-diagnosed GBM.
  Sampson, J.H. for the EGFRvIII Vaccine Group, J Neurosurg, 4/1/2008
• A phase I/II clinical trial evaluating RNA-loaded dendritic cells targeting human cytomegalovirus in patients with newly-diagnosed GBM.
  Mitchell, D.A., Archer, G.E., McGehee-Norman, S., Perry, B.A., Lally-Goss, D., Schmittling, R., Bigner, D.D., Friedman, A.H., Friedman, H.S., Reardon, D.A., Vredenbur..., J Neurosurg, 4/1/2008
• A curious history of the pineal gland in western mysticism and the occult.
  Gump, W.C., Whitlatch, L.W., Sampson, J.H., J Neurosurg, 4/1/2008
• Efficacy and immunologic effects of RNA-pulsed dendritic cell vaccines targeting human cytomegalovirus antigens in patients with glioblastoma.
  Mitchell, D.A., Archer, G.E., Bigner, D.D., Desjardins, A., Friedman, A.H., Friedman, H.S., Lally-Goss, D., Herndon, II, J.E., McGehee, S., McLendon, R.E., Perry, B., ..., Proc Am Assoc Cancer Res, 1/1/2008
• Efficacy of a phase II vaccine targeting cytomegalovirus antigens in newly-diagnosed GBM.
  Mitchell, D.A., Archer, G.E., Bigner, D.D., Friedman, H.S., Lally-Goss, D., Herndon, J.E., McGehee, S., McLendon, R., Reardon, D.A., Sampson, J.H., J Clin Oncol, 1/1/2008
• A genomic approach to define important and targetable molecular pathways in brain metastasis arising from solid tumors.
  Anders, C.K., Hsu, D., Acharya, C., McLendon, R., Sampson, J.H., Vredenburgh, J., Satterfield, D., Spector, N., Potti, A., Blackwell, K.L., J Clin Oncol, 1/1/2008
• Effect of EGFRvIII-targeted vaccine (CDX-110) on immune response and TTP when given with simultaneous standard and continuous temozolomide in patients with GBM.
  Sampson, J. H., Archer, G. E., Bigner, D. D., Davis, T., Friedman, H. S., Keler, T., Mitchell, D. A., Reardon, D.A., Sawaya, R., Heimberger, A.B., J Clin Oncol, 1/1/2008
• Stereotactic Body Radiosurgery of the Spine: The Duke Experience.
  Nelson, J.W., Yoo, D.S., Sampson, J.H., Isaacs, R.E., Larrier, N.A., Marks, L.B., Yin, F.F., Wu, Q.J., Wang, Z., Kirkpatrick, J.P., 50th Annual ASTRO Meeting, Int J Rad Oncol Biol Phys, 1/1/2008
• A phase II trial of sorafenib (nexavar) and protracted temozolomide for patients with recurrent glioblastoma.
  Reardon, D.A., Desjardins, A., Vredenburgh, J., Friedman, A.H., Sampson, J.H., Rich, J.N., Friedman, H.A., 13th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2008
• A phase I trial of dasatinib (sprycel) and erlotinib (tarceva) for patients with recurrent malignant glioma.
  Reardon, D.A., Desjardins, A., Vredenburgh, J., Friedman, A.H., Sampson, J.H., Gururangan, S., Rich, J.N., Friedman, H.A., 13th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2008
• Surgical resection of malignant glioma in adults less than 30 years old.
  Parker, S., Grossi, P., Sampson, J.H., Friedman, A.H., 13th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2008
• Evaluation of dose distribution in pre-operative versus post-operative stereotactic radiosurgery of single brain metastases.
  Aliabadi, H., You, D., Herndon, J.A., Sampson, J.H., Kirkpatrick, J., 13th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2008
• Efficacy and immunologic effects of rna-pulsed dendritic cell vaccines targeting human cytomegalovirus antigens in patients with glioblastoma.
  Mitchell, D.A., Archer, G.E., Bigner, D., Friedman, H.A., Lally-Goss, D., Perry, B.A., Herndon, J.A., McGehee, S., McClendon, R., Reardon, D., Sampson, J.H., 13th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2008
• The positive influence of temozolomide on the humoral and cell mediated (dth) responses to the EGFRvIII-targeted vaccine (cdx-110) in patients with gbm.
  Archer, G.E., Heimberger, A., Bigner, D., Davis, T., Friedman, H., Friedman, A., Keler, T, Mitchell, D., Reardon, D., Sawaya, R., Vredenburgh, J., Young, A., Rich, J.,..., 13th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2008
• Dosimetric and radiobiological impact of a high-definition micromultileaf collimator on radiosurgery of vestibular schwannomas.
  Meyer, J., Wu, Q.J., Sampson, J.H., Yin, F., Tucci, D., David, B., Zhiheng, W., Kirkpatrick, J., 13th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2008
• Surgical resection of malignant gliomas in elderly patients older than 70 years of age.
  Grossi, P., Parker, S., Sampson, J.H., Friedman, A.H., 13th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2008
• Effect of daclizumab on TReg counts and EGFRvIII-specific immune responses in GBM.
  Sampson, J.H., Archer, G.E., Bigner, D.D., Schmittling, R.J., Herndon, J.E., Davis, T., Friedman, H.S., Keler, T., Reardon, D.A., Mitchell, D.A., 45th Annual Meeting, American Society of Clinical Oncology, J Clin Oncol, 1/1/2008
• EGFRvIII vaccine (CDX-110) alone and with simultaneous temozolomide in patients with newly diagnosed, resected, EGFRVIII positive GBM.
  Heimberger, A., Davis, T., Keler, T., Vitale, L., Sampson, J.H., J Immunother, 1/1/2007
• Join now to see all

Lectures

• Chimeric Antigen Receptor (CAR) and Adoptive Cell Transfer 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
• Novel role for enhancing immunotherapy against pediatric brain tumors using hematopoietic stem cells. 
  San Francisco, CA - 11/21/2013
• Developmentally regulated antigens for immunologic targeting of medulloblastoma subtypes. 
  San Francisco, CA - 11/21/2013
• RNA nanoparticle vaccines re-direct host-immunity against intracranial malignancies. 
  San Francisco, CA - 11/21/2013
• Early results of a randomized trial of margin expansion in stereotactic radiosurgery for brain metastases. 
  Atlanta, GA - 9/22/2013
• Dose-finding and safety study of an oncolytic polio/rhinovirus recombinant against recurrent glioblastoma. 
  Chicago, IL - 5/31/2013
• Phase II Trial for Patients with Newly Diagnosed Glioblastoma (GBM) Treated with Gliadel Followed by Concurrent Radiation Therapy (RT), Temozolomide (TMZ) and Bevacizu... 
  Chicago, IL - 5/31/2013
• A Phase I/II study of adoptive T-cell therapy (ALT) and DC vaccination (DCV) during recovery from myeloablative chemotherapy and hematopoietic stem cell transplantatio... 
  Fort Lauderdale, FL - 5/16/2013
• A Phase I/II study of adoptive T-cell therapy (ALT) and DC vaccination (DCV) during recovery from myeloablative chemotherapy and hematopoietic stem cell transplantatio... 
  Fort Lauderdale, FL - 5/16/2013
• Engineering RNA nanoparticle vaccines to target malignant pediatric brain tumors. 
  Miami, FL - 4/24/2013
• Neurokinin-1 Receptor: A potential target to inhibit pediatric glioblastomas. 
  Washington, DC - 11/15/2012
• RNA Nanoparticle vaccines targeting pediatric and adult brain tumors. 
  Washington, DC - 11/15/2012
• Assessment of intratumoral Tregs and clinical outcomes in primary and recurrent GBM. 
  Washington, DC - 11/15/2012
• Myeloablative temozolomide increases antigen-specific CD8+ T-cell vaccine responses and is required for efficacious immunotherapy again intracerebral tumors. 
  Washington, DC - 11/15/2012
• Intravenous treatment with an EGFRvIII-targeted bispecific antibody successfully treats well-established brain tumors. 
  Washington, DC - 11/15/2012
• Development of immunocompetent syngeneic models of medulloblastoma for evaluation of immunotherapy. 
  Washington, DC - 11/15/2012
• Feasibility of amplified CD133(+) brain tumor stem cell RNA-pulsed dendritic cells for the treatment of patients with recurrent glioblastoma. 
  Washington, DC - 11/15/2012
• Targeting Cytomegalovirus (CMV) antigens for GBM immunotherapy. 
  Washington, DC - 11/15/2012
• Role of hematopoietic stem cells in enhancing the anti-tumor efficacy of adoptive cellular therapy. 
  Washington, DC - 11/15/2012
• Ex vivo generating central memory-like anti-tumor T cells to treat malignant brain tumors. 
  Washington, DC - 11/15/2012
• Adoptive cellular therapy during recovery from treatment-induced lymphopenia in pediatric patients with recurrent medulloblastoma and PNETs. 
  Washington, DC - 11/15/2012
• Phase I trial of gliadel plus temodar. 
  Chicago, IL - 11/9/2012
• Unarmed, tumor-specific antibody effectively treats brain tumors. 
  Chicago, IL - 11/9/2012
• Impact of concurrent and adjuvant bevacizumab on the risk of radiation necrosis following radiosurgery for recurrent glioma. 
  Boston, MA - 10/28/2011
• Joe Doupe Memorial Lecture. 
  Winnipeg, Manitoba, Canada - 9/8/2011
• Join now to see all

Other

• Novel Therapies in the Management of Malignant Brain Tumors: Bevacizumab and Surgery. 
  Chang, S., Sampson, J.H., Aghi, M., Theodosopoulos, P.V., CNS Neurosurger Webinars, Controversies in Neuro-Oncology: An Academic- Community Forum
  1/12/2010
• Cell-mediated immunotherapy of brain tumors. 
  Sampson, J.H., Doctoral Thesis Defense, Duke University
  12/5/1996